Research and innovation are at the heart of patient care, paving the way to the improved healthcare of tomorrow.

Frimley Health conducts trials across a range of specialities, addressing major issues such as heart disease, cancer and diabetes as well as studies into rarer conditions. This research works to improve treatment in hospitals, and may benefit yourself, your family, or your community in the future.

The impact of research and innovation is the focus of the Trust’s next health information event on Tuesday 23 January, 6.30-7.30pm. Featuring presentations from Associate Director for Research Matt Gardiner and Head of Research Swapna Thomas, the free online event will also look at the vital role played by patients and members of the public across Frimley Health to shape the future of healthcare. Some 2,000 patients are recruited into studies each year, improving treatments and helping to save lives.

Recent work at the Trust includes the Avert Dose trial, researching ways to provide a better recovery for stroke victims which has changed physio sessions in the first 24 hours after a stroke, improving patient care. The latest global innovations include a new table for hand surgery which provides a better, more comfortable experience for patients, who can now sit up and have their procedure under a local anaesthetic. This device is being trialled by other Trusts, with the potential to be sold around the world.

The online event is open to everyone who would like to learn more about research and innovation at Frimley Health, with an opportunity to put questions to Matt and Swapna at the end of the session. Simply register for the event here.